XBIT Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
6.1M
-2.0%
6.3M
-78.9%
29.8M
+392.1%
6.0M
-4.6%
6.3M
R&D
5.3M
+1.7%
5.2M
-79.5%
25.4M
+399.2%
5.1M
-4.8%
5.3M
SG&A
850.0K
-20.4%
1.1M
-75.7%
4.4M
+354.7%
967.0K
-3.3%
1.0M
Operating Income
-6146000
+2.0%
-6274000
+78.9%
-29755000
-392.1%
-6047000
+4.6%
-6336000
EBITDA
-5844000
+1.6%
-5942000
+79.8%
-29377000
-422.7%
-5620000
+4.7%
-5897000
Net Income
-6728000
-22.2%
-5505000
+79.5%
-26892000
-347.6%
-6008000
-242.1%
-1756000
EPS (Basic)
$-0.22
-22.2%
$-0.18
+79.5%
$-0.88
-340.0%
$-0.20
-233.3%
$-0.06
EPS (Diluted)
$-0.22
-22.2%
$-0.18
+79.5%
$-0.88
-340.0%
$-0.20
-233.3%
$-0.06
Shares (Diluted)
30.5M
+0.0%
30.5M
+0.0%
30.5M
+0.0%
30.5M
+0.0%
30.5M
XBiotech (XBIT) โ€” Financials